Assessment of the use and quick preparation of saliva for rapid microbiological diagnosis of COVID-19
South Health · 2024
DOI: 10.21142/sh-01-2024-e003 ↗Kurz gefasst
Fachartikel in der Zeitschrift South Health, 2024. Verfasst von Mariana Fernández-Pitto und 11 weiteren Autor:innen.
Abstract (Originalsprache)
COVID-19 is a very devastating pandemic infection caused by SARS-CoV-2, which originated in China and has currently spread all over the world (Chen et al., 2020).Rapid diagnosis of COVID-19 is essential for the management of patients mainly in the emergency department (Loeffelholz and Tang, 2020).Although some assays based on antigenantibody reaction have been commercialized to detect either antigens or antibodies (IgA, IgM, or IgG), the most sensitive tool to detect SARS-CoV-2 continues to be reverse-transcription real time polymerase chain reaction (RT-PCR) which specifically amplifies different genes encoded in the viral RNA from nasopharyngeal and/oropharyngeal swabs.Shortages in swabs for collecting nasopharyngeal and oropharyngeal samples as well as insufficient RNA extraction kits can lead to a critical situation during a pandemic in which a huge number of samples must be processed.Therefore, the main objective of this study was to evaluate the use of saliva as an alternative and easier-to-collect clinical sample to detect COVID-19.The diagnostic performance of nasopharyngeal and oropharyngeal swabs was compared to the performance of direct heated saliva to RNA extracted samples.Consecutive patients attending the Emergency Department of the Hospital Clinic of Barcelona, Spain, with laboratory or clinical-radiologic findings compatible with a diagnosis of COVID-19 were included in the study.Patients presenting infections or lesions in the oropharyngeal area were excluded.All patients included in the study had a primary diagnosis of COVID-19 by a RT-PCR from oropharyngeal and nasopharyngeal swabs samples.Oropharyngeal and nasopharyngeal swabs together with saliva samples were obtained from 51 patients clinically diagnosed as potentially having COVID-19 in the period from May to June 2020.The study was approved by the local ethical committee (HCB/2020/1001).
Zitieren
APA
Fernández-Pitto, M., Hurtado, J. C., Moreno-García, E., Rubio, E., Navarro, M., Valiente, M., Peiró, A., Capón, A., Seijas, N., Martínez, M. J., Casals-Pascual, C., & Vila, J. (2024). Assessment of the use and quick preparation of saliva for rapid microbiological diagnosis of COVID-19. South Health. https://doi.org/10.21142/sh-01-2024-e003
Vancouver
Fernández-Pitto M, Hurtado JC, Moreno-García E, Rubio E, Navarro M, Valiente M, et al. Assessment of the use and quick preparation of saliva for rapid microbiological diagnosis of COVID-19. South Health. 2024. doi:10.21142/sh-01-2024-e003
BibTeX
@article{FernndezPitto2024,
author = {Fernández-Pitto, Mariana and Hurtado, Juan C. and Moreno-García, Estela and Rubio, Elisa and Navarro, Mireia and Valiente, Marta and Peiró, Aida and Capón, Alicia and Seijas, Nuria and Martínez, Miguel J. and Casals-Pascual, Climent and Vila, Jordi},
title = {Assessment of the use and quick preparation of saliva for rapid microbiological diagnosis of COVID-19},
journal = {South Health},
year = {2024},
doi = {10.21142/sh-01-2024-e003}
}
EUVIMED